Teva Pharmaceutical Industries Ltd. (TEVA)
Update 5/11/2017: TEVA zig-zagged sharply in response to its earnings announcement. I exited at a $1.25 debit, or 29.4% of maximum potential profit.
Shares were down 1.7% over a day, or a -627% annual rate. The options position produced a 41.6% yield on debit for a +15,184% annual rate.
TEVA publishes earnings on Thursday before the opening bell.
I shall use the series of weekly options that trade for the last time eight days hence, on May 19.
Implied volatility stands at 39%, which is 3.9 times the VIX, a measure of the volatility of the S&P 500 index.
TEVA’s IV stands in the 54th percentile of its annual range and the peak of its most recent broad movement.
The price used for analysis was $31.04.
| Premium: | $1.77 | Expire OTM | |
| TEVA-iron fly | Strike | Odds | Delta |
| Long | 35.00 | 92.8% | 8 |
| Break-even | 33.27 | ||
| Short | 31.50 | 54.0% | 49 |
| Puts | |||
| Short | 31.50 | 45.7% | 51 |
| Break-even | 29.77 | ||
| Long | 28.00 | 89.36 | 9 |
The premium is 51% of the width of the position’s wings.
The risk/reward ratio is 1:1.
Decision for My Account
I have entered a position on TEVA as described above. The stock at the time of entry was priced at $31.41.
By Tim Bovee, Portland, Oregon, May 10, 2017
[…] entered five new positions: KSS, M, SNAP, TEVA and JWN. I entered into the last symbol in the list, JWN, a day earlier than normally would have. I […]
LikeLike
[…] partially exited TEVA and KSS, each for a profit and shall update their their analyses with results later today. I am […]
LikeLike